Montgomery Baxter Delworth, Owens Camille V, Najjar Rami Salim, Saad Mawadda
Montgomery Heart & Wellness Center, 10480 S Main St., Houston, TX 77025, USA.
Institute for Biomedical Sciences, Georgia State University, 161 Jesse Hill Jr Dr SE, Atlanta, GA 30303, USA.
Reports (MDPI). 2024 Nov 8;7(4):94. doi: 10.3390/reports7040094.
: Heart failure and kidney diseases often coexist and are difficult to clinically manage. Dysfunction in either organ exacerbates dysfunction in the other, potentially leading to cardiorenal syndrome (CRS). CRS has five different subtypes, with CRS type 5 being the most problematic given that it consists of an acute insult superimposed upon chronic CRS. Additionally, type 5 CRS can be complicated by heart failure-related cardiogenic shock (HF-CS), which is associated with increased hospitalizations and has a high 1-year mortality rate. The standard treatment for patients with HF-CS consists of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF) as tolerated, along with inotropic therapies and surgical mechanical left ventricular (LV) support, guided by invasive hemodynamic monitoring. : This case study reports the presentation of a 57-year-old man who presented with type 5 CRS who rapidly decompensated to stage E HF-CS and was effectively and safely treated with aggressive intravenous hydration, a defined plant-based diet (DPBD), and reduction of guideline-directed prescription medications without invasive hemodynamic monitoring. : Hydration, a DPBD, and a reduction in medication burden may be effective in CRS. Pilot studies are warranted to evaluate the efficacy of this intervention in CRS in a larger cohort.
心力衰竭和肾脏疾病常常并存,在临床上难以处理。任一器官功能障碍都会加重另一器官的功能障碍,这可能会导致心肾综合征(CRS)。CRS有五种不同的亚型,其中5型CRS最为棘手,因为它是由叠加在慢性CRS基础上的急性损伤构成。此外,5型CRS可能会并发与心力衰竭相关的心源性休克(HF-CS),这与住院率增加相关,且1年死亡率很高。HF-CS患者的标准治疗包括在耐受的情况下,针对射血分数降低的心力衰竭(HFrEF)进行指南指导的药物治疗,以及在有创血流动力学监测的指导下进行的正性肌力治疗和外科机械性左心室(LV)支持。本病例报告了一名57岁男性患者,他表现为5型CRS,迅速失代偿至E期HF-CS,并在未进行有创血流动力学监测的情况下,通过积极的静脉补液、明确的植物性饮食(DPBD)以及减少指南指导的处方药进行了有效且安全的治疗。补液、DPBD以及减轻药物负担可能对CRS有效。有必要开展初步研究以评估该干预措施在更大队列的CRS患者中的疗效。